XML 318 R290.htm IDEA: XBRL DOCUMENT v3.25.1
Basis of Operation - Liquidity and Going Concern (Detail)
$ in Thousands
Apr. 15, 2025
USD ($)
Subsequent Event | Tvardi Therapeutics, Inc. Merger Agreement | Cara Therapeutics, Inc.  
Cash and cash equivalents transferred to Legacy Tvardi $ 23,800